Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 1997

View Archived Issues

British Biotech: Q1 1997 highlights

Yoshitomi licenses immunosuppressant to Novartis

Cambridge NeuroScience awarded sixteenth SBIR grant

Improved efficacy of MEN-10755 related to apoptosis?

NIH approves study of marijuana in HIV-infected patients

GM-237354: a new antifungal sordarin derivative from Glaxo Wellcome

KBT-3022: pharmacokinetics and pharmacological effects in guinea pigs

Vanguard Medica and Abbott collaborate on development of new oral asthma therapy

Alza, Alkermes to codevelop RMP-7 for brain-specific drug delivery

Phase II results for IDEC-C2B8 in NHL

CV Therapeutics moves ranolazine to phase III

Combined pharmacological/genetic strategy for HIV shows promise

Gonal-F approved for marketing in U.S.

Antiproliferative activity of simvastatin demonstrated against human gliomas

Mutual Recognition Procedure concludes for Nasonex

DCLHb evaluated in critically ill patients

Oral desmopressin evaluated in bed-wetting children

Eltenac efficacy demonstrated in osteoarthritis

NIH grant to support development of CytRx's Protox

Preclinical data indicate effectiveness of Sertoli cells in neural regeneration

CellPro seeks new indication for CEPRATE SC System

FDA actively reviewing TOBI

Bacterial and viral infections focus of ArQule-RiboGene collaboration

Cancer cells being used to treat cancer

Briana Bio-Tech licenses peptide technology for chronic MS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...